GlassScriptPhysician profile
Stephen P Smik
NPI 1306957162
$1,501.31
in general payments reported to CMS, 2019-2025
13 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.09 · 2022: $301 · 2023: $384 · 2024: $585 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $258.20 | 2024 | Krystexxa |
| Organogenesis INC. | $253.11 | 2021-2025 | Puraply Wound Matrix, Puraply Antimicrobial |
| Paratek Pharmaceuticals, INC. | $239.03 | 2023-2025 | Nuzyra |
| Convatec INC. | $137.30 | 2023 | |
| Abbvie INC. | $124.99 | 2022 | |
| Smith+Nephew, INC. | $119.64 | 2024 | Grafix Pl |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $100.34 | 2022 | |
| Nevro Corp. | $86.67 | 2024 | Senza |
| Medshape, INC. | $57.97 | 2022 | |
| Mimedx Group, INC. | $43.43 | 2025 | |
| Linvatec Corporation | $43.13 | 2023 | Colink Plating System |
| Horizon Therapeutics Plc | $19.73 | 2023 | Krystexxa |
| Orthofix Medical, INC. | $17.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Smik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.